Also found in: Medical, Wikipedia.
Related to olmesartan: Olmesartan medoxomil


An angiotensin II receptor blocker drug, C24H26N6O3, used in the form of its medoxomil ester to treat hypertension.

[olme-, origin unknown + -sartan, angiotensin II receptor blocker suffix; see losartan.]


n olmesartán m
Mentioned in ?
References in periodicals archive ?
2019 for drugs for the combination of olmesartan / amlodipine (atc code according to who: C09db02)
M2 PHARMA-July 18, 2017-FDA approves Alembic Pharmaceuticals' ANDA for Olmesartan Medoxomil and Amlodipine tablets
Glenmark Pharmaceuticals has received final approval from the US health regulator for Amlodipine and Olmesartan Medoxomil tablets, used in the treatment of hypertension.
M2 EQUITYBITES-May 26, 2017-Glenmark Pharma gains US FDA approval for its blood pressure generic Olmesartan Medoxomil
2 -- Ajanta Pharma Limited, announces today US FDA* approval and launch of Amlodipine + Olmesartan Medoxomil Tablets in the US market through its wholly owned subsidiary Ajanta Pharma USA Inc.
This study aimed to assess the effectiveness of olmesartan in the prevention of new-onset AF and AF burden in atrioventricular block (AVB) patients with dual-chamber (DDD) pacemaker implantation.
5 times more likely to prescribe olmesartan than other ACE inhibitors or angiotensin II receptor blockers, and more than twice as likely to prescribe desvenlafaxine than other SSRIs and serotonin norepinephrine reuptake inhibitors (odds ratio, 2.
More than a thousand legal actions have been lodged in the US over the drug Olmesartan - also known as Olmetec.
Olmesartan medoxomil (trade name Benicar), the prodrug of olmesartan, is an angiotensin II receptor blocker (ARB) that was approved for use in the United States as an antihypertensive medication in 2002.
Olmesartan is a new ARB that was discovered during a systematic survey of the [AT.
Since then several others have been synthesized including valsartan irbesartan tel-misartan candesartan eprosartan and olmesartan.